Atrys HealthXMAD:ATRY +0.19%68 Days Inventory is 9.06 as of Dec. 2025, which is 51% below its 10-year median of 18.39. GuruFocus rates XMAD:ATRY with a GF Score™ of 68/100 and a GF Value™ of €3.11 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 639 Biotechnology companies, Atrys Health ranks better than 98.12% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Atrys Health's Average Total Inventories for the
six
months ended in Dec. 2025 was €2.0 Mil. Atrys Health's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €40.8 Mil.
Hence, Atrys Health's Days Inventory for the
six
months ended in Dec. 2025 was 9.06.
The historical rank and industry rank for Atrys Health's Days Inventory or its related term are showing as below:
XMAD:ATRY'
s Days Inventory Range Over the Past 10 Years
Min: 8.43 Med: 18.39 Max: 508.67
Current: 8.43
During the past 10 years, Atrys Health's highest Days Inventory was 508.67. The lowest was 8.43. And the median was 18.39.
XMAD:ATRY's Days Inventory is ranked better than 98.12% of 639
companies
in the Biotechnology industry
Industry Median: 183.97
vs XMAD:ATRY: 8.43
Atrys Health's Days Inventory
increased
from Dec. 2024 (8.85) to Dec. 2025 (9.06).
It might indicate that Atrys Health's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Atrys Health's Inventory Turnover for the
six
months ended in Dec. 2025 was 20.15.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Atrys Health's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.03.
Atrys Health (XMAD:ATRY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Atrys Health's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Atrys Health's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Atrys Health Days Inventory Related Terms
Atrys Health Days Inventory Historical Data
* Premium members only.
The historical data trend for Atrys Health's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:ATRY vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Atrys Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Atrys Health Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Atrys Health's Days Inventory distribution charts can be found below:
* The bar in red indicates where Atrys Health's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Atrys Health (XMAD:ATRY) has a Days Inventory of 9.06 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Atrys Health and its competitors. This is 51% below median its historical median of 18.39. Over the past decade, Atrys Health's Days Inventory has ranged from 8.43 to 508.67. According to the industry distribution chart, Atrys Health ranks #12 out of 639 companies in the Biotechnology industry, placing it in the top 1.9%.
Is Atrys Health's Days Inventory too high?
Atrys Health's current Days Inventory of 9.06 is 51% below median its 10-year median of 18.39. Over the past 10 years, this metric has ranged from a low of 8.43 to a high of 508.67. The Biotechnology industry median Days Inventory is 183.97. Atrys Health's value of 9.06 is 95.1% below this industry median. Based on the distribution chart, Atrys Health ranks #12 out of 639 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Atrys Health has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atrys Health's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Atrys Health ranks #12 out of 639 companies for Days Inventory. This places Atrys Health in the top 2% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.97. Atrys Health's value of 9.06 is 95.1% below this benchmark. Historically, Atrys Health's own Days Inventory has ranged from 8.43 to 508.67 over the past decade. While the company's 10-year median is 18.39 vs. the industry median of 183.97, Atrys Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.97, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Atrys Health's current Days Inventory of 9.06 is 95.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Atrys Health and its competitors. For the Biotechnology industry, the median Days Inventory is 183.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atrys Health's current Days Inventory is 9.06, which is 51% below median its own 10-year median of 18.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atrys Health stock overvalued right now?
Based on GuruFocus' analysis, Atrys Health (XMAD:ATRY) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.11, compared to a current price of €2.58 — trading 17% below its estimated fair value. The current Days Inventory is 9.06, which is 51% below median its 10-year median of 18.39 and 95.1% below the Biotechnology industry median of 183.97. Atrys Health's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Atrys Health (XMAD:ATRY), the current Days Inventory is 9.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Atrys Health (XMAD:ATRY) Overvalued in 2026?
Based on GuruFocus' analysis, Atrys Health stock appears to be undervalued.
The current stock price of €2.58 is trading 17% below its estimated GF Value™ of €3.11.
GuruFocus considers Atrys Health to be Modestly Undervalued.
Key valuation signals for XMAD:ATRY:
Days Inventory: 9.06 (51% below median its 10-year median of 18.39)
GF Value™: €3.11 vs. price of €2.58 (17% below fair value)
Industry Position: 95.1% below the Biotechnology median (#12 of 639)
No single metric tells the full story. See the XMAD:ATRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.
68GF Score
Get the complete analysis for XMAD:ATRY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:ATRY has been successfully added to your 
